Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Biogen
Deal Size : Undisclosed
Deal Type : Collaboration
AbCellera Collaborates with Biogen to Discover Antibodies for Neurological Conditions
Details : The collaboration aims to discover antibodies for a novel target that enables the delivery of biotherapeutics to the brain for indications in neuroscience.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
November 03, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Biogen
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Universite de Montreal
Deal Size : Undisclosed
Deal Type : Collaboration
IRICoR, UdeM, IRIC and Valence Discovery collaborate to design novel drug candidates
Details : The collaboration builds on research from the team of Dr. Daniel Levesque at UdeM, and focuses on the design of highly selective modulators of the Nur77/RXR nuclear receptor complex, a promising new pharmacological target for movement disorders.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 03, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Universite de Montreal
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Cerevel Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Cerevel will utilize Cyclica’s Ligand Express® and Ligand Design™ platforms to screen, identify, evaluate and optimize targets to develop neuroscience medicines.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 27, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Cerevel Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Invetx
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The proprietary platform combines industry-leading technologies from partners AbCellera, Twist Bioscience and WuXi Biologics to develop fully species-specific, optimized and half-life-extended monoclonal antibodies (mABs) for veterinary use.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
July 16, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Invetx
Deal Size : Undisclosed
Deal Type : Collaboration